“Introduction of new products, increasing healthcare expenditure, increasing health consciousness, technological advancement, etc. will drive the global needle free drug delivery market to become US$ 192 Billion by 2020”, says RNCOS.
Noida, UP -- (SBWIRE) -- 05/29/2015 -- According to a new research report by RNCOS entitled, "Global Needle Free Drug Delivery Market Outlook 2020", US dominates the needle free drug delivery market in the world and the emerging countries in the Asia Pacific region are expected to capture a significant share in the Global Needle Free Drug Delivery Market.
Oral drug delivery system is considered to be the most demanded needle free drug delivery system in the world, however jet injectors and transdermal systems are witnessing inclining demand in the global needle free drug delivery market and are expected to grow stupendously in future. The market, which stood at US$ 112 Billion in 2014, has the potential to report a significant growth in the next six years. The market is anticipated to grow at 9.4% CAGR to become US$ 192 Billion by 2020, with emerging markets such as China and India showcasing the fastest growth. GSK, Novartis, 3M, Endo International, Boehringer Ingelheim Group and AstraZeneca are some of the major needle free drug delivery companies.
Research Analysis & Highlights
The report is spread in over 75 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Global Needle Free Drug Delivery Industry. The study presents transparent picture major needle free drug delivery systems such as Jet Injector, Micro Needle, Transdermal, Oral and Inhaled systems including the factors affecting their growth. The research further covers global needle free drug delivery system industry, detailed analysis of geographical segments, applications of needle free drug delivery systems, pipeline analysis, as well as Mergers and Acquisitions.
The report also covers detailed information about active market players in the Global Needle Free Drug Delivery Industry, including small and large players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the global needle free drug delivery system industry, providing an in-depth research and prudent analysis of the key segments.
Some of the report's key highlights include:
- Major needle free drug delivery technology such as Jet Injector drug delivery system, Micro Needle drug delivery system, Transdermal drug delivery system, Oral drug delivery system and Inhaled drug delivery system and their growth
- Needle free drug delivery applications- Insulin delivery, pain management, vaccine delivery, Pediatric injections and others and their share in global needle free drug delivery systems market
- Geographical Segmentation- Europe, US, Asia Pacific and Rest of the World
- Mergers and Acquisition followed by premium deals during the year 2014
- Leading Players and their share in global needle free drug delivery system industry
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM751.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.